Dalian BIO-CHEM Company Limited
603360.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CN¥307 | CN¥300 | CN¥448 | CN¥416 |
| % Growth | 2.3% | -33% | 7.8% | – |
| Cost of Goods Sold | CN¥201 | CN¥195 | CN¥307 | CN¥256 |
| Gross Profit | CN¥107 | CN¥105 | CN¥141 | CN¥160 |
| % Margin | 34.7% | 34.9% | 31.5% | 38.5% |
| R&D Expenses | CN¥18 | CN¥17 | CN¥19 | CN¥13 |
| G&A Expenses | CN¥0 | CN¥38 | CN¥38 | CN¥9 |
| SG&A Expenses | CN¥40 | CN¥38 | CN¥51 | CN¥18 |
| Sales & Mktg Exp. | CN¥0 | CN¥1 | CN¥13 | CN¥9 |
| Other Operating Expenses | CN¥3 | CN¥4 | CN¥2 | CN¥2 |
| Operating Expenses | CN¥61 | CN¥60 | CN¥71 | CN¥33 |
| Operating Income | CN¥45 | CN¥45 | CN¥70 | CN¥128 |
| % Margin | 14.7% | 15% | 15.6% | 30.7% |
| Other Income/Exp. Net | -CN¥7 | CN¥10 | -CN¥10 | -CN¥0 |
| Pre-Tax Income | CN¥38 | CN¥55 | CN¥60 | CN¥128 |
| Tax Expense | CN¥7 | CN¥1 | CN¥10 | CN¥23 |
| Net Income | CN¥33 | CN¥42 | CN¥50 | CN¥91 |
| % Margin | 10.8% | 13.9% | 11.2% | 21.9% |
| EPS | 0.047 | 0.083 | 0.1 | 0.18 |
| % Growth | -42.9% | -17% | -44.4% | – |
| EPS Diluted | 0.047 | 0.083 | 0.1 | 0.18 |
| Weighted Avg Shares Out | 701 | 502 | 502 | 505 |
| Weighted Avg Shares Out Dil | 701 | 502 | 502 | 505 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥2 | CN¥0 | CN¥17 | CN¥19 |
| Interest Expense | CN¥8 | CN¥7 | CN¥7 | CN¥2 |
| Depreciation & Amortization | CN¥0 | CN¥23 | CN¥17 | CN¥17 |
| EBITDA | CN¥46 | CN¥72 | CN¥90 | CN¥138 |
| % Margin | 15.1% | 23.9% | 20.1% | 33.2% |